Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.9 USD | -0.21% | +0.47% | -30.63% |
May. 07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
May. 07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.63% | 2.64B | |
+16.68% | 121B | |
+13.65% | 107B | |
-5.42% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.22% | 15.31B | |
+3.18% | 14.08B | |
+24.84% | 11.74B |
- Stock Market
- Equities
- MLTX Stock
- News MoonLake Immunotherapeutics
- Wedbush Raises MoonLake Immunotherapeutics' PT to $61 From $33 After Positive Topline Phase 2 MIRA Results, Keeps Outperform Rating